ArticleCVIR endovascular2026
Sheathless microcatheter: a new approach for musculoskeletal arterial embolization.
Article in CVIR endovascular, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionOngoing developments in interventional radiology have enabled the treatment of various musculoskeletal inflammatory disorders via super-selective embolization of abnormal areas of neovascularization. The current convention is to utilize vascular sheaths in these procedures. This study explored a single-center experience with a novel approach utilizing a sheathless microcatheter cannulation technique without the conventional vascular sheath. MATERIAL AND
methodsA single-center retrospective chart review was conducted, including all eligible adult patients for whom a super-selective embolization was performed to treat an MSK inflammatory disorder between August 2024 and March 2025. The pre-procedural medical records and imaging were reviewed to determine satisfaction of inclusion criteria. The fluoroscopic images from the angiography suite and procedure notes were reviewed to determine technical success and immediate complications.
resultsTwenty-seven procedures were performed for 19 patients. The average age was 47.5 ± 10 years old. The majority of patients were female (13; 68.5%). The most common procedure indication was for treatment of plantar fasciitis with 14 procedures (51.9%). The embolic material of choice was imipenem-cilastatin in all but one procedure (26; 96.3%). The commonest microcatheter size was 1.7 French (21; 77.8%), and the preferred access vessel was the common femoral artery (17; 63%). The technical success rate was 100% without immediate complications. No major post-procedural complications were encountered. Only one minor access site hematoma complication was reported.
conclusionThis novel sheathless microcatheter approach was found to be feasible, safe, and effective without major complications within our limited sample size.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.